journal article·2019-09Open access

Design of core–shell gold‐coated superparamagnetic nanoparticles as a theranostic for targeted magnetic resonance imaging and photoablation therapy

Daniel Goldstein, Chendong Han, Matthew Mahan, Amber Doiron

Micro & Nano Letters· Volume 14· Issue 11

Abstract

A theranostic refers to the concept of integrating diagnostic and therapeutic capabilities into a single platform. In this work, a layer of gold was reduced around superparamagnetic iron oxide (SPIO) nanoparticles to be used as a theranostic for magnetic resonance imaging and photoablation. In addition, a gold shell was included in the particle design to improve biocompatibility, stabilise nanoparticles in suspension, and allow robust surface functionalisation. Gold‐coated SPIO nanoparticles of 8 nm in diameter exhibited surface plasmon resonance while also maintaining their superparamagnetic nature. Energy dispersive spectroscopy confirmed the existence of gold at the surface of the nanoparticles, the thickness of which was 0.5 nm based on transmission electron microscopy measurements. To demonstrate their potential for targeted therapies, nanoparticles were targeted to VCAM‐1 on human umbilical vein endothelial cells and detected via darkfield microscopy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering Binghamton University P.O. Box 6000 Binghamton USA

Department of Electrical and Biomedical Engineering University of Vermont Votey 313, 33 Colchester Ave Burlington VT USA

References (24)

Show source-provided references
1. 10.1002/anie.20060286610.1002/anie.200602866 ↗
2. 10.1016/j.mad.2004.07.00910.1016/j.mad.2004.07.009 ↗
3. 10.1006/taap.2001.924010.1006/taap.2001.9240 ↗
4. 10.1126/science.111439710.1126/science.1114397 ↗
5. 10.1016/j.msec.2016.02.05210.1016/j.msec.2016.02.052 ↗
6. 10.1021/la701305f10.1021/la701305f ↗
7. 10.1039/b820624d10.1039/b820624d ↗
8. 10.1021/jp054342910.1021/jp0543429 ↗
9. 10.1021/ja038085210.1021/ja0380852 ↗
10. 10.1016/S0002‐9394(14)71911‐710.1016/S0002‐9394(14)71911‐7 ↗
11. 10.1533/9780857097545.110.1533/9780857097545.1 ↗
12. 10.1039/b806051g10.1039/b806051g ↗
13. 10.1038/nprot.2008.110.1038/nprot.2008.1 ↗
14. 10.1016/j.jhazmat.2011.11.07310.1016/j.jhazmat.2011.11.073 ↗
15. 10.1038/ncomms1287910.1038/ncomms12879 ↗
16. 10.1039/c0nr00621a10.1039/c0nr00621a ↗
17. 10.1002/andp.1908330030210.1002/andp.19083300302 ↗
18. 10.1021/am506516r10.1021/am506516r ↗
19. 10.1021/nl035253f10.1021/nl035253f ↗
20. VCAM‐1‐targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide‐induced inflammation under shear flow and cellular magnetic resonance imaging in vitro
21. 10.1088/2053‐1591/aa84e610.1088/2053‐1591/aa84e6 ↗
22. 10.1177/15330346040030010410.1177/153303460400300104 ↗
23. 10.1039/c3tb20446d10.1039/c3tb20446d ↗
24. 10.1016/j.impact.2018.02.00710.1016/j.impact.2018.02.007 ↗